Zhongyuan Union Healthcare (600645.SH) subsidiary VUM02 injection clinical trial application has obtained the notice of acceptance.

Talent Financial News APP News, Zhongyuan Joint-He (600645.SH) announced that its wholly-owned subsidiary, Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., obtained the "Acceptance Notice" for the clinical trial application of VUM02 Injection issued by the Center for Drug Evaluation (CDE) of the National Medical Products Administration on June 23, 2025. The acceptance number is CXSL2500507.